Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplant; Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05459337
What this trial is testing

Multidisciplinary Support to Access Living Donor Kidney Transplant (MuST AKT)

Who this might be right for
Living Donor Kidney Transplantation
University of Alberta 66
Not applicableNot Yet RecruitingNCT04496037
What this trial is testing

Mechanistic Evaluation of Treatments for Acute Antibody-Mediated Rejection of the Kidney Transplant

Who this might be right for
Transplant; Complication, Rejection
Imperial College London 170
Post-approval studies (Phase 4)Ended earlyNCT00420472
What this trial is testing

CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS.

Who this might be right for
Kidney Transplantation
Hoffmann-La Roche
Testing effectiveness (Phase 2)Study completedNCT03762473
What this trial is testing

Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection

Who this might be right for
Renal Transplant Infection
University of Alabama at Birmingham 89
Post-approval studies (Phase 4)Study completedNCT00965094
What this trial is testing

Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients

Who this might be right for
Chronic Renal Failure
Novartis Pharmaceuticals 36
Post-approval studies (Phase 4)Study completedNCT06044493
What this trial is testing

MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Chong Kun Dang Pharmaceutical 158
Post-approval studies (Phase 4)Study completedNCT00154232
What this trial is testing

Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 46
Post-approval studies (Phase 4)Study completedNCT01895049
What this trial is testing

Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

Who this might be right for
Kidney TransplantationCytomegalovirus
Helio Tedesco Silva Junior 171
Not applicableActive Not RecruitingNCT06564649
What this trial is testing

PROACT Pilot Trial

Who this might be right for
Kidney Transplant Rejection
University of British Columbia 60
Large-scale testing (Phase 3)WithdrawnNCT04420364
What this trial is testing

Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease

Who this might be right for
COVIDKidney Transplant; ComplicationsImmunosuppression
Brigham and Women's Hospital
Large-scale testing (Phase 3)Study completedNCT01254214
What this trial is testing

Journeys to Wellness: A Transplant Candidate Study

Who this might be right for
End-stage Renal Disease
University of Minnesota 63
Not applicableStudy completedNCT04541914
What this trial is testing

Diagnostic Efficacy of Molecular Diagnostic Method for AMR in ABOiKT

Who this might be right for
ABO Blood Type Incompatible Kidney TransplantationAntibody-mediated Rejection
Seoul National University Hospital 30
Not applicableStudy completedNCT00359814
What this trial is testing

Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation

Who this might be right for
Heart Transplantation
Hannover Medical School 23
Not applicableEnrolling By InvitationNCT06336863
What this trial is testing

Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression

Who this might be right for
Kidney Transplant Immunosuppression
University of Texas Southwestern Medical Center 24
Not applicableStudy completedNCT05465863
What this trial is testing

Humoral and Cellular İmmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Children With Chronic Kidney Diseases

Who this might be right for
Chronic Kidney Disease 5DChronic Kidney Disease 5T
Istanbul University - Cerrahpasa 101
Not applicableStudy completedNCT00513175
What this trial is testing

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+8 more
University of California, San Francisco 44
Testing effectiveness (Phase 2)Study completedNCT00235300
What this trial is testing

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

Who this might be right for
Cadaveric Donor Renal TransplantationAcute Renal Allograft RejectionInduction Therapy
Genzyme, a Sanofi Company 240
Testing effectiveness (Phase 2)Study completedNCT00820911
What this trial is testing

Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 175
Testing effectiveness (Phase 2)WithdrawnNCT03327064
What this trial is testing

A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer

Who this might be right for
Non-melanoma Skin Cancer
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT00309309
What this trial is testing

Metabolic and Renal Effects of Rosiglitazone in Kidney Transplant

Who this might be right for
Kidney Transplant
Mario Negri Institute for Pharmacological Research 10
Next Page